NASDAQ: ITRM
Iterum Therapeutics PLC Stock Ownership - Who owns Iterum Therapeutics?

Insider buying vs selling

Have Iterum Therapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ITRM insiders and whales buy or sell their stock.

ITRM Shareholders

What type of owners hold Iterum Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP29.13%11,651,597$11.77MInsider
Brenton Karl Ahrens4.33%1,733,580$1.75MInsider
Canaan X LP4.33%1,733,170$1.75MInsider
James Healy4.33%1,732,668$1.75MInsider
Patrick J. Heron3.87%1,547,322$1.56MInsider
Vijay K. Lathi3.64%1,456,303$1.47MInsider
Sofinnova Venture Partners IX LP3.07%1,226,514$1.24MInsider
Shahzad Malik2.17%868,161$876.84kInsider
Ronald Hunt0.90%359,366$362.96kInsider
New Leaf Venture Partners LLC0.86%345,020$348.47kInstitution

1 of 3

ITRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM2.74%56.97%
MDCX22.53%71.99%Net SellingNet Selling
PLUR0.05%99.95%
GRCE29.10%50.93%
STTK65.11%26.18%Net Buying

Iterum Therapeutics Stock Ownership FAQ

Who owns Iterum Therapeutics?

Iterum Therapeutics (NASDAQ: ITRM) is owned by 2.74% institutional shareholders, 56.97% Iterum Therapeutics insiders, and 40.28% retail investors. Ra Capital Management LP is the largest individual Iterum Therapeutics shareholder, owning 11.65M shares representing 29.13% of the company. Ra Capital Management LP's Iterum Therapeutics shares are currently valued at $11.59M.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.